Total Payments
$73,640
2024 Payments
$1,537
Companies
36
Transactions
702
Medicare Patients
38,620
Medicare Billing
$1.8M
Payment Breakdown by Category
Travel$28,837 (39.2%)
Consulting$25,659 (34.8%)
Food & Beverage$15,115 (20.5%)
Research$2,418 (3.3%)
Other$1,550 (2.1%)
Education$61.01 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $28,837 | 30 | 39.2% |
| Consulting Fee | $25,659 | 2 | 34.8% |
| Food and Beverage | $15,115 | 646 | 20.5% |
| Unspecified | $2,418 | 13 | 3.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,550 | 6 | 2.1% |
| Education | $61.01 | 5 | 0.1% |
Payments by Type
General
$71,222
689 transactions
Research
$2,418
13 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Roche Diabetes Care, Inc. | $39,369 | 17 | $0 (2019) |
| Novo Nordisk AS | $17,374 | 34 | $0 (2023) |
| Novo Nordisk Inc | $2,488 | 124 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $1,795 | 15 | $0 (2024) |
| Amgen Inc. | $1,577 | 46 | $0 (2024) |
| SANOFI PASTEUR INC. | $1,309 | 15 | $0 (2023) |
| Medtronic MiniMed, Inc. | $1,125 | 10 | $0 (2020) |
| Boehringer Ingelheim International GmbH | $1,085 | 11 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,018 | 61 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $851.04 | 51 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,537 | 64 | Novo Nordisk Inc ($341.67) |
| 2023 | $4,664 | 98 | Novo Nordisk AS ($1,631) |
| 2022 | $2,564 | 92 | Novo Nordisk AS ($786.96) |
| 2021 | $1,751 | 91 | Amgen Inc. ($285.60) |
| 2020 | $2,719 | 82 | Tandem Diabetes Care, Inc. ($1,550) |
| 2019 | $29,896 | 85 | Roche Diabetes Care, Inc. ($17,993) |
| 2018 | $5,218 | 90 | Novo Nordisk AS ($2,802) |
| 2017 | $25,291 | 100 | Roche Diabetes Care, Inc. ($21,330) |
All Payment Transactions
702 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia, XGEVA | Food and Beverage | In-kind items and services | $125.15 | General |
| Category: Bone Health | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.45 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Diabetes Care | ||||||
| 12/10/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $15.32 | General |
| Category: Insulin Pump | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/01/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Endocrinology | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/10/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Rare Disease | ||||||
| 10/03/2024 | Abbott Laboratories | ALINITY (Device) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Diagnostics | ||||||
| 10/01/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: Diabetes | ||||||
| 09/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Diabetes Care | ||||||
| 09/06/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Endocrinology | ||||||
| 09/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Bone Health | ||||||
| 08/27/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $24.53 | General |
| 08/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $109.97 | General |
| Category: Endocrinology | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| NN SELECT Results Meeting Philadelphia | Novo Nordisk AS | $1,631 | 9 |
| NN9535-4352 | Novo Nordisk AS | $786.96 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 57 | 9,710 | 22,507 | $881,135 | $473,401 |
| 2022 | 56 | 9,679 | 27,588 | $931,823 | $487,232 |
| 2021 | 55 | 9,710 | 21,400 | $754,020 | $455,516 |
| 2020 | 58 | 9,521 | 20,335 | $651,889 | $416,846 |
Total Patients
38,620
Total Services
91,830
Medicare Billing
$1.8M
Procedure Codes
226
All Medicare Procedures & Services
226 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 808 | 2,213 | $343,611 | $185,701 | 54.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 20 | 2,040 | $71,400 | $37,565 | 52.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 779 | 2,086 | $41,720 | $21,442 | 51.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 526 | 1,626 | $42,460 | $21,073 | 49.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 723 | 1,115 | $33,776 | $18,270 | 54.1% |
| 83721 | Ldl cholesterol level | Office | 2023 | 514 | 1,592 | $24,861 | $16,281 | 65.5% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 46 | 337 | $24,240 | $15,330 | 63.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 506 | 1,628 | $28,521 | $15,316 | 53.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 205 | 221 | $22,418 | $13,039 | 58.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 811 | 2,214 | $14,823 | $12,659 | 85.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 152 | 427 | $19,030 | $10,702 | 56.2% |
| 82248 | Bilirubin level, direct | Office | 2023 | 779 | 2,092 | $19,568 | $10,207 | 52.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 727 | 1,124 | $20,314 | $9,892 | 48.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 117 | 118 | $8,800 | $8,155 | 92.7% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 53 | 53 | $8,238 | $7,579 | 92.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 48 | 48 | $11,562 | $7,298 | 63.1% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 97 | 142 | $21,600 | $5,623 | 26.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 453 | 616 | $8,526 | $4,673 | 54.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 122 | 164 | $7,558 | $4,671 | 61.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 33 | $6,771 | $4,432 | 65.5% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 39 | 43 | $6,375 | $4,089 | 64.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 145 | 153 | $3,825 | $3,749 | 98.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 22 | 76 | $4,837 | $3,480 | 71.9% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 148 | 209 | $6,403 | $3,453 | 53.9% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2023 | 64 | 64 | $5,948 | $3,153 | 53.0% |
About Dr. William Biggs, M.D
Dr. William Biggs, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Amarillo, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033280862.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Biggs, M.D has received a total of $73,640 in payments from pharmaceutical and medical device companies, with $1,537 received in 2024. These payments were reported across 702 transactions from 36 companies. The most common payment nature is "Travel and Lodging" ($28,837).
As a Medicare-enrolled provider, Biggs has provided services to 38,620 Medicare beneficiaries, totaling 91,830 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 226 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Amarillo, TX
- Active Since 11/13/2006
- Last Updated 12/01/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1033280862
Products in Payments
- DC ACCU-CHEK Diabetes Management Solutions, Cables, Software, Kits and Accessories (Device) $39,369
- Ozempic (Drug) $13,249
- Tresiba (Drug) $4,019
- t:slim X2 insulin pump (Device) $1,550
- EVENITY (Biological) $1,302
- C DIFFICILE (Drug) $1,249
- Minimed 670G System (Device) $1,108
- FARXIGA (Drug) $1,003
- JARDIANCE (Drug) $775.78
- Victoza (Drug) $443.21
- TOUJEO (Drug) $348.60
- Dexcom G6 Transmitter (Medical Supply) $327.95
- SYNTHROID (Drug) $309.87
- TRULICITY (Drug) $256.88
- Omnipod (Device) $236.79
- INVOKANA (Drug) $222.77
- JANUVIA (Drug) $220.98
- t:slim X2 Insulin Pump with Control-IQ (Device) $217.26
- TEPEZZA (Drug) $198.03
- PROCLAIM (Device) $192.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Amarillo
Kenny Brantley, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $190,929
Endocrinology, Diabetes & Metabolism $190,929
Mr. Cesar Arias, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $68,730
Endocrinology, Diabetes & Metabolism $68,730
Susan Wingo, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $9,061
Endocrinology, Diabetes & Metabolism $9,061
Dr. Stephen Usala, Md Phd, MD PHD
Endocrinology, Diabetes & Metabolism — Payments: $4,441
Endocrinology, Diabetes & Metabolism $4,441
Dr. Maria Cristina Caga-Anan, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $4,249
Endocrinology, Diabetes & Metabolism $4,249
Dr. Debora Carrizo, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $25.83
Endocrinology, Diabetes & Metabolism $25.83